Faizan Farooque

Faizan Farooque

InvestorPlace Contributor

Expertise: Real estate investment trusts (REITs), SPACs, Cryptocurrencies

Education: BSc (Hons) Degree in Applied Accounting, Oxford Brookes University; Introduction to Data Analysis Using Excel, Rice University; Excel Skills for Business: Intermediate, Macquarie University

About Faizan
Faizan Farooque is a finance journalist who has reported on the latest trends in the stock market for many years. He helps people by providing advice about saving and investing and keeping up with what’s happening in the financial world.

Faizan is writing for InvestorPlace.com, GuruFocus, and TipRanks and has previously worked as a financial journalist and data analyst for S&P Global. He can analyze company filings from sources like SEC, FINRA, and others to help identify potential investment opportunities. Researching specific industries is also something he does to provide industry insight for clients.

Faizan deeply understands the market and how to read the financial tea leaves to anticipate where things are headed. His expertise gives readers an insider’s perspective on what’s happening in the finance world so they can make smart decisions.

Recent Articles

Wait For a Pullback Before You Buy Advanced Micro Devices Stock

By Faizan Farooque, InvestorPlace Contributor

AMD stock has fallen off slightly from its 52-week high, but investors should wait for shares to lose a bit more steam before buying in.

4 Biometric Stocks for Heightened Security

By Faizan Farooque, InvestorPlace Contributor

Biometric stocks are an excellent investment right now, as businesses reconfigure processes to become more contactless due to Covid-19.

Pullback and Possible Split Make Amazon Extremely Attractive

By Faizan Farooque, InvestorPlace Contributor

AMZN stock looks very attractive after the tech sell-off. Expect this one to rally on strong fundamentals and concrete growth strategies.

Moderna Is Ready To Rally After 2-Month Market Correction

By Faizan Farooque, InvestorPlace Contributor

MRNA stock is ready to rally once again, as the company gears up to deliver millions of Covid-19 vaccines in 2021 and help end this crisis.

As Big Data Meets Insurance, Lemonade Stock Looks Great Right Here

By Faizan Farooque, InvestorPlace Contributor

Lemonade stock will only go up from hereon in as its AI-driven business model gives it a competitive advantage over traditional insurers.

Load More